Michael Horner to Indans
This is a "connection" page, showing publications Michael Horner has written about Indans.
Connection Strength
0.228
-
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res. 2007 Jul; 93(1-3):131-5.
Score: 0.069
-
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol. 2006 Oct; 9(5):603-5.
Score: 0.062
-
Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
Score: 0.053
-
A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates. Neurocase. 2001; 7(2):105-10.
Score: 0.045